Anthrax spores make an essential contribution to vaccine efficacy

Infection and Immunity

Volumn 70, Issue 2, 2002, Pages 661-664

  Brossier, Fabien ^a   Levy, Martine ^a   Mock, Michèle ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX VACCINE; FORMALDEHYDE; TOXIN;

ANIMAL EXPERIMENT; ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL SPORE; BACTERIAL VIRULENCE; DRUG EFFICACY; FEMALE; GUINEA PIG; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFECTION PREVENTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPTICEMIA; TOXEMIA;

ANIMALS; ANTHRAX; ANTHRAX VACCINES; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACTERIAL TOXINS; FEMALE; FORMALDEHYDE; GUINEA PIGS; HUMANS; MICE; SPORES, BACTERIAL;

EID: 0036151303     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Fulminant meningitis due to Bacillus anthracis in 11-year-old girl during Ramadan
2. Role of toxin functional domains in anthrax pathogenesis
3. Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax
4. Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin
5. Anthrax vaccine: Evidence for safety and efficacy against inhalational anthrax
6. Germination of Bacillus anthracis spores within alveolar macrophages
7. Anthrax: The disease in relation to vaccines
8. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill
9. Experimental anthrax vaccines: Efficacy of adjuvants combined with protective antigen against an aerosol Bacillus anthracis spore challenge in guinea pigs
10. Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques
11. Immunization against anthrax with aromatic compound-dependent (Aro-) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen
12. Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants
13. Efficacy of a standard human anthrax vaccine against Bacillus anthracis spore challenge in guineapigs
14. Anthrax toxins
15. Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs
16. Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig
17. Protective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological markers
18. Bacterial SLH domain proteins are non-covalently anchored to the cell surface via a conserved mechanism involving wall polysaccharide pyruvylation
19. Molecular characterization of the Bacillus anthracis main S-layer component: Evidence that it is the major cell-associated antigen
20. Evidence for plasmid-mediated toxin production in Bacillus anthracis
21. Contribution of individual toxin components to virulence of Bacillus anthracis
22. Construction of Bacillus anthracis mutant strains producing a single toxin component
23. Protective immunity, induced by Bacillus anthracis toxin-deficient strains
24. Search for correlates of protective immunity, conferred by anthrax vaccine
25. Molecular tools for the study of transcriptional regulation in Bacillus anthracis
26. Anthrax vaccines: Past, present and future
27. Current status of immunization against anthrax: Old vaccines may be here to stay for a while
28. Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity
29. Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunity
30. Association of the encapsulation of Bacillus anthracis with a 60-megadalton plasmid
31. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores
32. -) Bacillus anthracis
33. Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice
34. Differences in susceptibility of inbred mice to Bacillus anthracis
35. Non-toxigenic derivatives of the Ames strain of Bacillus anthracis are fully virulent for mice: Role of plasmid pXO2 and chromosome in strain-dependent virulence
36. The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation